Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-103P is a processed pseudogene related to the U6 small nuclear RNA gene family, which are short, conserved non-coding RNAs involved in the spliceosomal removal of mRNA introns. RNU6-103P itself does not produce a functional RNA or protein product. Pseudogenes such as RNU6-103P arise through retrotransposition events, most commonly mediated by LINE-1 (L1) elements, and represent genomic relics rather than active genetic elements[2]. They are generally considered non-functional, though some pseudogenes can rarely act as competing endogenous RNAs or regulatory elements, but there is no data suggesting such a function for RNU6-103P[4][6]. RNU6-103P is not considered a therapeutic or biological target, nor is it implicated directly in disease or targeted by drugs[1][3][4].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 103, pseudogene (RNU6-103P).